A medicare contractor's approach to developing local coverage determinations for infectious-disease molecular diagnostics

This article attempts to present the backdrop against which Medicare carriers are chartered to make local coverage decisions, and it provides a triangular paradigm for expressing the regulatory, collaborative and evaluative boundaries within which this decision-making takes place. Although infectious disease molecular diagnostic testing will be underscored, this model can be extrapolated to the full complement of Medicare policy issues.